Marketing Dosage Units "Difficult" To Determine For Certain OTCs - H&R
This article was originally published in The Tan Sheet
Executive Summary
Foreign marketing data for classes of OTC drugs without specific dosage instructions should be based on annual sales of the active ingredient rather than the finished product, raw material supplier Haarmann & Reimer states in March 21 comments on FDA's "material time, material extent" proposed rule.
You may also be interested in...
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says
Non-Monograph Drugs Interim Marketing Preservation Urged By CHPA
FDA's proposed rule on "material time and material extent" criteria for inclusion of drug conditions in the OTC review would "effectively terminate" the monograph process, CHPA maintains in a March 22 letter to the agency.